Literature DB >> 3928770

Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.

B G Shearer, N J Legakis.   

Abstract

The role of lipopolysaccharide (LPS) in determining the permeability of the outer membrane of Pseudomonas aeruginosa to carbenicillin and gentamicin was investigated. The susceptibility of P. aeruginosa isolates to smooth LPS-specific phages and to pyocin R1 gave indirect evidence of an altered LPS structure in strains resistant to carbenicillin, gentamicin, or both. Some secondary mutation, however, also appeared to be required for acquisition of the antibiotic-resistant phenotype. Phage- and pyocin-resistant variants demonstrating both wild-type and mutant responses to the drugs were subsequently isolated. Four-, eight-, and 16-fold increases in resistance to carbenicillin, supersusceptible responses to gentamicin, or both, were associated with a number of the LPS-altered mutants. The results supported the hypothesis that a primary mutation involving LPS, in combination with some undefined secondary mutation, determines the permeability of the outer membrane to carbenicillin and to gentamicin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928770     DOI: 10.1093/infdis/152.2.351

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

Authors: 
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

4.  Importance of carbenicillin and gentamicin cross-resistant serotype 0:12 Pseudomonas aeruginosa in six Athens hospitals.

Authors:  N J Legakis; N Koukoubanis; K Malliara; D Michalitsianos; J Papavassiliou
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

5.  Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

Authors:  N J Legakis; L S Tzouvelekis; A Makris; H Kotsifaki
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 6.  Virulence versus resistance.

Authors:  K M Krasinski
Journal:  Bull N Y Acad Med       Date:  1987-04

7.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

8.  Regulation of membrane permeability by a two-component regulatory system in Pseudomonas aeruginosa.

Authors:  Yanping Wang; Unhwan Ha; Lin Zeng; Shouguang Jin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Identification of rfbA, involved in B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa serotype O5.

Authors:  T Dasgupta; J S Lam
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6.

Authors:  T Dasgupta; T R de Kievit; H Masoud; E Altman; J C Richards; I Sadovskaya; D P Speert; J S Lam
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.